Veeru Kasivisvanathan

ORCID: 0000-0002-0832-382X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Radiomics and Machine Learning in Medical Imaging
  • Bladder and Urothelial Cancer Treatments
  • Urologic and reproductive health conditions
  • MRI in cancer diagnosis
  • Cardiac, Anesthesia and Surgical Outcomes
  • COVID-19 and healthcare impacts
  • Urinary and Genital Oncology Studies
  • Pediatric Urology and Nephrology Studies
  • Renal cell carcinoma treatment
  • Health and Medical Research Impacts
  • Urological Disorders and Treatments
  • Genital Health and Disease
  • Diversity and Career in Medicine
  • Renal and Vascular Pathologies
  • Kidney Stones and Urolithiasis Treatments
  • Pelvic floor disorders treatments
  • Clinical practice guidelines implementation
  • Healthcare Systems and Public Health
  • Cancer, Lipids, and Metabolism
  • Urinary Bladder and Prostate Research
  • Surgical Simulation and Training
  • Testicular diseases and treatments
  • Innovations in Medical Education

University College London
2016-2025

British Association of Urological Surgeons
2018-2024

University College London Hospitals NHS Foundation Trust
2015-2024

University College Hospital
2015-2024

University Hospitals Bristol and Weston NHS Foundation Trust
2024

University Hospitals Bristol NHS Foundation Trust
2024

Peter MacCallum Cancer Centre
2022-2023

Royal London Hospital
2021-2023

Urological Society of Australia and New Zealand
2020-2023

Collaborative Research Group
2023

Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence limited.In multicenter, randomized, noninferiority trial, we assigned clinical suspicion of prostate cancer had previously undergo MRI, Men the MRI-targeted group underwent (without cores) if MRI was...

10.1056/nejmoa1801993 article EN New England Journal of Medicine 2018-03-19

Case reports have been a long held tradition within the surgical literature. Reporting guidelines can improve transparency and reporting quality. However, recent consensus-based for case (CARE) are not surgically focused. Our objective was to develop report guidelines.The CARE statement used as basis Delphi consensus. The questionnaire administered via Google Forms conducted using standard methodology. A multidisciplinary group of surgeons others with expertise in were invited participate....

10.1016/j.ijsu.2016.08.014 article EN cc-by-nc-nd International Journal of Surgery 2016-09-09

Case series have been a long held tradition within the surgical literature and are still frequently published. Reporting guidelines can improve transparency reporting quality. No guideline exists for case series, our recent systematic review highlights fact that key data being missed from such reports. Our objective was to develop series.A Delphi consensus exercise conducted determine items include in guideline. Items included those identified previous on SCARE Guidelines The questionnaire...

10.1016/j.ijsu.2016.10.025 article EN cc-by-nc-nd International Journal of Surgery 2016-10-20

Magnetic resonance imaging (MRI) with targeted biopsy is an appealing alternative to systematic 12-core transrectal ultrasonography (TRUS) for prostate cancer diagnosis, but has yet be widely adopted.To determine whether MRI only was noninferior TRUS biopsies in the detection of International Society Urological Pathology grade group (GG) 2 or greater cancer.This multicenter, prospective randomized clinical trial conducted 5 Canadian academic health sciences centers between January 2017 and...

10.1001/jamaoncol.2020.7589 article EN JAMA Oncology 2021-02-08

Abstract Multiparametric MRI is the optimal primary investigation when prostate cancer suspected, and its ability to rule in out clinically significant disease relies on high-quality anatomical functional images. Avenues for achieving consistent acquisitions include meticulous patient preparation, scanner setup, optimised pulse sequences, personnel training, artificial intelligence systems. The impact of these interventions final images needs be quantified. imaging quality (PI-QUAL) scoring...

10.1007/s00330-024-10795-4 article EN cc-by European Radiology 2024-05-24

No AccessJournal of UrologyAdult Urology1 Mar 2013Transperineal Magnetic Resonance Image Targeted Prostate Biopsy Versus Transperineal Template in the Detection Clinically Significant Cancer Veeru Kasivisvanathan, Robert Dufour, Caroline M. Moore, Hashim U. Ahmed, Mohamed Abd-Alazeez, Susan C. Charman, Alex Freeman, Clare Allen, Kirkham, Jan van der Meulen, and Mark Emberton KasivisvanathanVeeru Kasivisvanathan Division Surgery Interventional Sciences, University College London, United...

10.1016/j.juro.2012.10.009 article EN The Journal of Urology 2012-10-11

Our aim was to evaluate whether transperineal (TP) MRI-targeted prostate biopsy (TBx) may improve the detection of clinically significant cancer (csPCa), defined as International Society Urological Pathology ≥2, in comparison transrectal (TR) TBx.A multicenter retrospective cohort study comprising patients who underwent MRI-guided conducted. To address possible benefits TP-TBx (PCa) and csPCa, a undergoing were compared TR-TBx. Multivariable logistic regression analyses performed assess...

10.1097/ju.0000000000002802 article EN The Journal of Urology 2022-09-09

Introduction Prostate MRI is a well-established tool for the diagnostic work-up men with suspected prostate cancer (PCa). Current recommendations advocate use of multiparametric (mpMRI), which composed three sequences: T2-weighted sequence (T2W), diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE). Prior studies suggest that biparametric (bpMRI) approach, omitting DCE sequences, may not compromise clinically significant detection, though there are limitations to these studies, it...

10.1136/bmjopen-2022-070280 article EN cc-by BMJ Open 2023-04-01
Francesco Giganti Alexander Ng Aqua Asif Vinson Wai‐Shun Chan Marimo Rossiter and 89 more Arjun Nathan Pramit Khetrapal Louise Dickinson Shonit Punwani Chris Brew‐Graves Alex Freeman Mark Emberton Caroline M. Moore Clare Allen Veeru Kasivisvanathan Adriano Basso Dias Aiman Haider Amara Khan Angela Tong Antti Rannikko Anu Kenttämies Ardeshir R. Rastinehad Armando Stabile Arnauld Villers Ash Tewari Aytekin Oto Bas Israël Byron Gaing Carmen Chi-Min Cho Carolina Aulló González Chau Hung Lee Christian Wetterauer Claudia Kesch Daniel A. Adamo Daniel Margolis Daniel José López Ruiz David Margel Declan G. Murphy Enrique Gómez‐Gómez Felix K.‐H. Chun Felix Preißer Francis Thomas Geert Villeirs Giancarlo Marra Gianluca Giannarini Giorgio Brembilla G. Robert Guglielmo Manenti Hannes Cash Ingrid Potyka Jan Philipp Radtke Jeffrey J. Leow Jens Theysohn Jim C. Hu Jingfei Ma Lance A. Mynderse Lars Boesen Lars Budäus Lars Schimmöller Lee Alexander Grant Luca Orecchia Maarten de Rooij Maneesh Ghei Marco Gatti Mariano Volpacchio Markku H. Vaarala Martina Pecoraro Massimo Imbriaco Matthias Roethke M.A. Rodríguez Cabello Nazar Miguel Paras Singh Nicola Muirhead Peter Ka‐Fung Chiu Philip Ryan Philippe Puech Pierre Mozer Pieter De Visschere Públio César Cavalcante Viana Raphaële Renard Penna Réka Novotta Renato Cuocolo Richard O’Sullivan Rossano Girometti Sangeet Ghai Scott E. Eggener Tharakeswara Bathala Tho Pham Tristan Barrett Valeria Panebianco Vibeke Løgager Vinayak Wagaskar Yaara Ber Y. Lebras

Background High variability in prostate MRI quality might reduce accuracy cancer detection. Purpose To prospectively evaluate the of scanners taking part control phase global PRIME (Prostate Imaging Using ± Contrast Enhancement) trial using Prostate Quality (PI-QUAL) standardized scoring system, give recommendations on how to improve protocols, and establish whether could be improved by these recommendations. Materials Methods In prospective clinical (PRIME), for each scanner, centers...

10.1148/radiol.231130 article EN Radiology 2023-10-01
Coming Soon ...